Anti Coagulation System · UK public procurement notice

-Following an assessment of the UK market, DAWN AC has been identified as the only supplier able to meet the Trust’s mandatory technical, clinical, and interoperability requirements for an acute NHS anticoagulation service. Other systems assessed do not provide the necessary functionality to safely manage both warfarin and direct oral anticoagulant (DOAC) patients at scale, nor do they support required integrations with existing Trust electronic patient record and laboratory systems. This constitutes an absence of genuine competition for technical reasons.

-Alternative systems were reviewed and determined not to be reasonable substitutes, as they are primarily designed for primary care or low‑volume use and lack essential features required in an acute hospital setting, including comprehensive DOAC management, automated dosing support, patient communication functionality, and full system interoperability. As such, no alternative solution can meet the Trust’s minimum requirements without unacceptable clinical, operational, and patient safety risk.

• The incumbent RAID system is being withdrawn and will no longer be supported after 30 November 2026. The Trust must implement a replacement system within a defined timeframe to ensure continuity of a critical, high‑risk clinical service supporting approximately 7,000 patients. A competitive procurement would not deliver a viable alternative solution and would not change the outcome, as only one supplier is capable of meeting the Trust’s requirements. The direct award is therefore proportionate and necessary.